Showing results (131-140 of 170) with videos related to
Sort By:
Pageof 17
International Journal of Molecular Medicine|February 6, 2026
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancerEunsun Jung, Ji Young Kim, Dongmi Ko, et al.British Journal of Pharmacology|July 29, 2025
IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signallingSun-Ae Park, Hee Jung Kim, Lee Kyung Kim, et al.Chemotherapy|February 28, 2015
Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract CancerEun Joo Kang, Yoon Ji Choi, Jung Sun Kim, et al.Investigational New Drugs|November 28, 2009
Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancerHee Yeon Seo, Hyun Joo Lee, Ok Hee Woo, et al.American Journal of Clinical Oncology|February 3, 2005
Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancerJae Hong Seo, Chul Won Choi, Byung Soo Kim, et al.Cancer Research and Treatment|December 19, 2015
Pirarubicin, UFT, Leucovorin Chemotherapy in Non-embolizable and Transcatheter Arterial Chemoembolization-Failed Hepatocellular Carcinoma Patients; A Phase II Clinical StudyKyong Hwa Park, So Young Yoon, Sang Cheul Oh, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean populationSle Gi Lo Han, Kyong Hwa Park, Jae Sook Sung, et al.Journal of Human Genetics|July 5, 2007
Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean populationHae-Yun Jung, Jae Sook Sung, Young Mi Whang, et al.Therapeutic Advances in Medical Oncology|December 20, 2021
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, et al.Cancer Research and Treatment|December 19, 2015
Oral Etoposide, Ifosfamide and Cisplatin in the Treatment of Extensive Disease Small Cell Lung CancerSeok Jin Kim, Hwa Jung Sung, Kyong Hwa Park, et al.Pageof 17